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ABSTRACT
A young man presented to the emergency room in
extremis and deteriorated into a state of pulseless
electrical activity. Bedside echocardiography by
emergency medicine physicians was crucial to the
clinical decision to implement thrombolytic therapy
for suspected massive pulmonary embolus.
INTRODUCTION
Pulmonary embolism (PE), a leading cause of death
in the United States resulting in 200,000 deaths per
year, can rapidly progress to fatality.1,2 Ten percent of
patients with PE will die within the first hour of the
event.1
The clinical presentation of PE ranges from nonspecific
symptoms to severe shock and even death, primarily
secondary to right ventricular failure.2,3 Myocardial
infarction (MI), arrhythmias, and heart block
secondary to PE have also been proposed as causes
of death in massive PE.2
Historically, treatment of PE has consisted of
anticoagulation with unfractionated intravenous
heparin. Heparin prevents further clot progression by
interfering with the intrinsic coagulation pathway, but
does not actively remove the thrombus. It is important
to stress that heparin, while decreasing long term
morbidity and mortality from recurrent emboli, does
not improve pulmonary perfusion or right ventricular
hemodynamics in the acute setting.3-7
Two advances have led to significant improvement in
the classification and treatment of pulmonary
embolism. Echocardiographic assessment of the right
ventricle is utilized to risk stratify patients, while
thrombolytic therapy produces active blood clot lysis
in the pulmonary arteries. We present a case of
massive PE in which bedside echocardiography and
thrombolytics played a pivotal role in the patient’s
survival.
CASE
Paramedics responded to the home of a 33-year-old
male with difficulty breathing. The brother heard a
loud noise in the adjacent room where the patient was
“lying on the floor gasping for air.” Vital signs were
blood pressure (BP) 50/palpation, heart rate (HR)
134, respiratory rate (RR) 28, and oxygen saturation
(SaO2), 87 % on room air. His lungs were clear, the
heart rhythm was sinus tachycardia, and his skin was
cool and moist. The patient was rapidly transported
to the hospital, with slightly improved vital signs (BP
72/palp, Sao2 98%) on 15L non-rebreather mask.
He repeatedly remarked in short sentences that he
was going to pass out.
On physical exam the patient was an alert, diaphoretic
and cyanotic young male in severe respiratory distress.
He denied medications or illicit drug use. The family
stated he had no medical conditions other than a
traumatic fracture of his ankle two months prior in a
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90, RR 30s, temperature 96.4, and SaO2 unable to
obtain. He was tachypneic with clear lungs and no
wheeze or rales. He was tachycardic, without a
murmur or JVD. Radial and pedal pulses were
diminished. There was 1+ pedal edema bilaterally with
no calf erythema or tenderness.
ED Course: The treating physician suspected a
pulmonary embolus and ordered an IV heparin bolus
followed by heparin infusion. A stat CXR, EKG, and
labs were ordered. The patient was intubated for
respiratory failure using etomidate and succinylcholine
under RSI protocol. Endotracheal tube placement
was visually confirmed; Sa02 was 90% with manual
ventilation and equal breath sounds. The patient rapidly
deteriorated into pulseless electrical activity (PEA)
and Advanced Cardiac Life Support was initiated
immediately.  A  bedside  subxiphoid  view
echocardiogram was performed using the emergency
department’s ultrasound machine, revealing negligible
wall motion and right ventricular dilatation without left
ventricular enlargement (Figure 1). The high clinical
suspicion for PE in this patient, coupled with
echocardiographic evidence of right ventricular (RV)
dysfunction prompted the use of thrombolytics. Tissue
plasminogen activator was front-end loaded (15 mg
bolus, followed by 50 mg over 30 minutes, then 35
mg over 60 minutes) within minutes of the PEA. In
less than five minutes, the patient regained peripheral
pulses with a systolic blood pressure of 96; forty
minutes later his BP was 140/115, HR 140, SaO2
97% on mechanical ventilation.
Hospital course: The patient was admitted to the ICU.
Pulmonary angiogram demonstrated moderate sized
PE in the left 2nd order branches and in the right upper
lobe peripheral branches. Minor nasopharyngeal
bleeding complicated the hospital course. The patient
was successfully extubated and discharged from the
hospital with no neurological deficits.
DISCUSSION
Echocardiography has changed physicians’ approach
to the classification and diagnosis of PE. A patient with
a PE can be placed in one of three categories: “small”—
hemodynamically (HD) stable with no evidence of RV
dysfunction; “submassive”—HD stable but
echocardiographic evidence of RV dysfunction; and
“massive”—RV failure, shock, HD unstable.1,5,6,8
Patients with small PEs generally do well with
anticoagulation alone.6 Patients with submassive PE
have an increased risk of mortality compared to
patients with normal echocardiograms.6,7,9,10 The early
use of thrombolytics in this group can substantially
improve and even reverse RV dysfunction.4,6,11
Whether this physiologic effect translates into an
improvement in morbidity and mortality is unclear.6,11,12
Figure 1. Subcostal four chamber view taken at
time of initial cardiac arrest.
Figure 2.  Apical four chamber view taken at
approximately two and a half hours after
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Patients with cardiogenic shock secondary to RV failure
(“massive PE”) present a particular challenge to the
managing physician. Patients with massive PE account
for a small percentage of total PEs, but have a high
mortality rate (18-58%) that is even higher (65%-95%)
if they require CPR.2,6,13,14 Bedside ultrasound is often
a critical imaging modality because these patients are
frequently too unstable for definitive “gold standard”
testing outside of the emergency department. Although
it is not an effective screening tool for all cases of
suspected PE, echocardiography is ideally suited for
detecting the RV dysfunction secondary to massive
PE.8-10,14-17 While more definitive echocardiographic
signs of RV dysfunction include hypokinesis, abnormal
septal motion, and tricuspid regurgitation, a simple
qualitative measurement of RV dilatation (diameter
greater than or equal to LV) can be used as evidence
of PE.8,15,17
There is a paucity of literature concerning thrombolytic
therapy for massive PE, but available evidence
supports its use in this setting.6,7,11 A study comparing
thrombolytics to heparin in massive PE was halted after
only 8 patients; all 4 patients treated with thrombolytics
and anticoagulation survived, while all 4 patients treated
with anticoagulation alone died.18 The American
College of Emergency Physicians (ACEP) supports
the consideration of thrombolytic therapy in confirmed
massive PE. They further advocate the consideration
of thrombolytics in suspected massive PE based upon
bedside echocardiographic findings of RV
dysfunction.19
Although the use of thrombolytic therapy in the setting
of cardiac arrest from suspected PE was historically
contraindicated, there have been no randomized
studies to support this prohibition of its use. On the
contrary, there have been nearly 100 reported cases
of successful cardiac resuscitations in which
thrombolytics were used. Bailen notes there is no
evidence that thrombolysis used during CPR for PE
causes an increase of hemorrhagic complications, and
thus advocates thrombolysis during CPR for suspected
cases of PE.2
Emergency physicians often care for patients who
present in cardiopulmonary arrest. While PE accounts
for only 2-15% of unexpected sudden deaths, there is
limited, but compelling, evidence that thrombolytics
can be a life saving intervention.2 The goal would be
to identify those patients whose arrest is most likely
secondary to PE and would thus benefit from
thrombolytics. History of present illness is essential,
but often limited. Physical exam is most often non-
specific in PE, and therefore objective ancillary
evidence is crucial in this situation. When patients with
PE present in cardiac arrest, the rhythm is usually PEA
or asystole.2 In one series, twenty-five of thirty-six
consecutive patients with unexplained cardiac arrest
presented  in  PEA.13  Transesophageal
echocardiograms were performed on all patients in
PEA, fourteen of whom showed evidence (RV
enlargement with no LV enlargement) consistent with
PE. Nine of these fourteen patients with PEA and
echocardiographic evidence of right ventricular strain
had a PE, while none of the non-PEA patients had
PE. Although further study is needed, it seems
reasonable to conclude that, in cases of unexplained
PEA and a high clinical suspicion of PE, bedside
echocardiographic screening for RV dilation could be
used to support the consideration of potentially life-
saving thrombolysis.
The risk of serious bleeding complications, especially
intracranial hemorrhage (ICH), accompanies the use
of thrombolytics. Data compiled from five studies
showed an ICH rate of 1.9% (6/312) in patients given
thrombolytics for PE. Of note, no patient under the
age of 50 suffered an ICH. When combined with 455
additional patients from other case series, the
frequency of ICH for PE thrombolysis patients
dropped to 1.2%.20 When considering thrombolysis,
clinicians should seek out any known absolute
contraindications, but should also weigh the relatively
low rate of ICH against the extremely high mortality
from massive PE.
We report on the successful use of TPA in a case of
massive PE that swiftly deteriorated to PEA. Bedside
echocardiography reinforced the clinical suspicion of
PE and was the determinant factor in the decision to
use thrombolytics. Aggressive treatment with
thrombolytic therapy was very likely the key
intervention that facilitated a successful resuscitation
with normal neurologic outcome. Fear of adverse
outcomes from bleeding and lack of a definitivePage  11 The California Journal of Emergency Medicine VII:1, Jan-Mar, 2006
diagnosis are likely the factors that dissuade physicians
from using thrombolytics in suspected massive PE.
Rates of ICH, however, are relatively low compared
to the mortality rates of massive PE. Bedside
echocardiography can be a powerful diagnostic tool
in cases of HD instability or cardiac arrest from
suspected massive PE and could potentially trigger
life-saving intervention.
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